[logo] HealthTree Foundation
more_vert
close
person Sign In / Create Account

The Hopeful Future of Multiple Myeloma in 2016 with Dr. Kenneth Anderson, MD, PhD, Dana Farber Cancer Institute

The Hopeful Future of Multiple Myeloma in 2016 with Dr. Kenneth Anderson, MD, PhD, Dana Farber Cancer Institute image

The Hopeful Future of Multiple Myeloma in 2016 with Dr. Kenneth Anderson, MD, PhD, Dana Farber Cancer Institute

Podcast
event Jan 22, 2016 / 11:00AM MST
link icon facebook logo X logo linkedin logo reddit logo email icon

Event Description

Dr. Kenneth Anderson, MD, PhD Dana Farber Cancer Institute Interview Date: January 22, 2016 

 Dr. Kenneth Anderson, MD, PhD of the Dana Farber Cancer Institute joins Myeloma Crowd Radio to outline the most important work being done in multiple myeloma in the coming year. He shares the top 5 areas of immunotherapy and the work in particular in checkpoint inhibitors (PD1 and PDL-1) that is looking very hopeful. He applauds the recent approvals of 7 new myeloma treatments in 2015 but says "our job is not done." Dr. Anderson emphasizes the importance of clinical trials to make new treatments available in the clinic for us all. He believes that although stem cell transplant is still a very core therapy, the myeloma "backbone" of treatments may evolve to include immunotherapies like vaccines, monoclonal antibodies, and oral therapies. He notes the continued importance of studying the genomics in myeloma and continues to work on "blowing the fuse" of myeloma's survival by altering its signaling. He believes that myeloma has weaknesses that can be taken advantage of and is working in the lab to provide ways to turn it against itself. He looks forward to a new year with better tolerated HDAC inhibitors, oral agents, vaccines, additional progress in checkpoint inhibitors and the study of how gene expressions are controlled and why they mutate (epigenetics). 

multiple myeloma 

Thanks to our episode sponsor, Takeda Oncology

Schedule & Agenda

Event panelist Dr. Kenneth Anderson & Jenny Ahlstrom
11:00 AM
Discussion
Dr. Kenneth Anderson & Jenny Ahlstrom

Speakers & Moderators

The panelist Jennifer Ahlstrom
Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

Thanks to our sponsors:
Johnson and Johnson logo
Sanofi logo
Pfizer logo
GSK logo
Regeneron logo
All HealthTree resources available anywhere, anytime
Download our App
Download iOS App Download Android App
iphone app mockup
newsletter icon

Get the Latest Multiple Myeloma Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.